Detalhe da pesquisa
1.
Gemtuzumab Ozogamicin Monotherapy Is a Well-tolerated Palliative Chemotherapy Option in Pediatric Multiply Relapsed Acute Myeloid Leukemia: A Multicenter Case Series and Review of the Literature.
J Pediatr Hematol Oncol
; 45(8): 436-444, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807192